Kurt von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), bought 31,359 shares at $2.68 ($84K) on 2015-08-13, disclosed to the SEC on 2015-08-17.
Open-market purchase of $84k CBAY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.